Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Altebainawi A"'
Autor:
Al Sulaiman K, Aljuhani O, Korayem GB, AlFaifi M, Alharthi AF, Alshehri A, Alaboud MS, Alzahrani IS, Alenazi BA, Alanazi FF, Alrashidi H, Alotaibi SM, Aloufi K, Alotaibi RM, Alalawi M, Altebainawi AF, Alshami MY, Alenazi AA, Abalkhail GA, Bin Naheet R, Alnasr RMA, Alrashed M, Al Mutairi FE, Albarqi KJ, Alshammari RS, Abunayyan NM, Aldhmadi WJ, Vishwakarma R
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3161-3171 (2024)
Khalid Al Sulaiman,1– 5 Ohoud Aljuhani,6 Ghazwa B Korayem,7 Mashael AlFaifi,8 Abdullah F Alharthi,9 Asma Alshehri,1,10 Mashael S Alaboud,11 Ibtesam Saeed Alzahrani,2 Batoul Abdullah Alenazi,2 Fai Farhan Alanazi,2 Hessah Alrashidi,2 Sara Mohammad Al
Externí odkaz:
https://doaj.org/article/853723f7f35b4cd8af1b4ba807fdbd15
Publikováno v:
International Journal of General Medicine, Vol Volume 12, Pp 255-262 (2019)
Mohamad Aljofan,1 Ali Altebainawi,2–4 Mubarak Nsha Alrashidi21Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan; 2Pharmacy College, Hail University, Hail, Kingdom of Saudi Arabia; 3Aja Pharmaceut
Externí odkaz:
https://doaj.org/article/07c19f202b934b21b9b147c9f4b1d83b
Autor:
Aljuhani, Ohoud, Al Sulaiman, Khalid, Korayem, Ghazwa B., Altebainawi, Ali F., Alshaya, Abdulrahman, Nahari, Majed, Alsamnan, Khuzama, Alkathiri, Munirah A., Al-Dosari, Bodoor S., Alenazi, Abeer A., Alsohimi, Samiah, Alnajjar, Lina I., Alfaifi, Mashael, AlQussair, Nora, Alanazi, Reem M., Alhmoud, Munirah F., Alanazi, Nadin L., Alkofide, Hadeel, Alenezi, Aljawharah M., Vishwakarma, Ramesh
Publikováno v:
In Saudi Pharmaceutical Journal May 2024 32(5)
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Mashael AlFaifi, Majed Nahari, Alaa Almagthali, Abrar K. Thabit, Raghad Alhajaji, Reham Alharbi, Khawla Kahtani, Abeer A. Alenazi, Aisha Alharbi, Munirah M. Alghwainm, Sara M. Alotaibi, Yazeed S. Alghamdi, Samar Alotaibi, Shaden H. Alonazi, Jumanah M. Almutairi, Ramesh Vishwakarma
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 9, Pp 1492-1499 (2023)
Background: Favipiravir is an oral antiviral, that might treat COVID-19 by enhancing viral eradication, particularly in patients with mild-to-moderate disease. Yet, the findings on the use of favipiravir in critically ill patients with COVID-19 are i
Externí odkaz:
https://doaj.org/article/79d18e3055ca4f70a4b4422350e807d0
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali Altebainawi, Reham Alharbi, Maha Assadoon, Ramesh Vishwakarma, Nadia H. Ismail, Asma A. Alshehri, Faisal E. Al Mutairi, Mashael AlFaifi, Abdullah F. Alharthi, Abeer A. Alenazi, Mai Alalawi, Omar Al Zumai, Hussain Al Haji, Sarah T. Al Dughaish, Abdulrahman S. Alawaji, Haifa A. Alhaidal, Ghassan Al Ghamdi
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Previous studies have shown mortality benefits with corticosteroids in Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of methylprednisolone over dexamethasone in COVID-19, and this has not bee
Externí odkaz:
https://doaj.org/article/b943874714ce4ccb84fd5d336272a740
Autor:
Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Meshal S. Alotaibi, Noura A. Alrakban, Ragia H. Ghoneim, Ramesh Vishwakarma, Abdulrahman I. Al Shaya, Shmeylan Al Harbi, Jawaher Gramish, Dahlia M. Almutairi, Ghada Alqannam, Faisal F. Alamri, Abdullah F. Alharthi, Mashael Alfaifi, Abdullah Al Amer, Abeer A. Alenazi, Norah Bin Aydan, Mai Alalawi, Khalid Al Sulaiman
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 7, Pp 1210-1218 (2023)
Background: Oseltamivir has been used as adjunctive therapy in the management of patients with COVID-19. However, the evidence about using oseltamivir in critically ill patients with severe COVID-19 remains scarce. This study aims to evaluate the eff
Externí odkaz:
https://doaj.org/article/06e3d4711b5747b583db96bbbf412425
Autor:
Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B Korayem, Aisha Alharbi, Ali F. Altebainawi, Shatha A. Aldkheel, Sarah G. Alotaibi, Ramesh Vishwakarma, Hanan Alshareef, Samiah Alsohimi, Mashael AlFaifi, Abdulrahman Al Shaya, Haifa A. Alhaidal, Raghad M. Alsubaie, Hessah Alrashidi, Khalid J. Albarqi, Dalal T. Alangari, Reem M. Alanazi, Noora M. Altaher, Hasan M. Al-Dorzi
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
Tocilizumab (TCZ) is recommended in patients with COVID-19 who require oxygen therapy or ventilatory support. Despite the wide use of TCZ, little is known about its safety and effectiveness in patients with COVID-19 and renal impairment. Therefore, t
Externí odkaz:
https://doaj.org/article/ca2f1083e62d4c88939688b4397622d0
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Hisham A. Badreldin, Ghazwa B. Korayem, Abeer A. Alenazi, Ahlam H. Alharbi, Albandari Alghamdi, Alaa Alhubaishi, Ali F. Altebainawi, Mohammad Bosaeed, Rand Alotaibi, Ahad Alawad, Nirvana Alnajjar, Khalid Bin Saleh, Walaa A. Sait, Samiah Alsohimi, Meshari M. Alanizy, Sarah A. Almuqbil, Ibrahim Al Sulaihim, Ramesh Vishwakarma, Mai Alalawi, Fatimah Alhassan, Suliman Alghnam
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Previous studies have shown that non-critically ill COVID-19 patients co-infected with other respiratory viruses have poor clinical outcomes. However, limited studies focused on this co-infections in critically ill patients. This
Externí odkaz:
https://doaj.org/article/04c83215625a45baa6163d5fb8f70490
Autor:
Al Sulaiman, Khalid, Aljuhani, Ohoud, Korayem, Ghazwa B., Altebainawi, Ali F., AlFaifi, Mashael, Nahari, Majed, Almagthali, Alaa, Thabit, Abrar K., Alhajaji, Raghad, Alharbi, Reham, Kahtani, Khawla, Alenazi, Abeer A., Alharbi, Aisha, Alghwainm, Munirah M., Alotaibi, Sara M., Alghamdi, Yazeed S., Alotaibi, Samar, Alonazi, Shaden H., Almutairi, Jumanah M., Vishwakarma, Ramesh
Publikováno v:
In Journal of Infection and Public Health September 2023 16(9):1492-1499
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.